NCT01097863

Brief Summary

The purpose of this study is to validate the improvements to the inversion indicator.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
280

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Mar 2010

Shorter than P25 for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2010

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

March 31, 2010

Completed
2 days until next milestone

First Posted

Study publicly available on registry

April 2, 2010

Completed
29 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2010

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2010

Completed
1.2 years until next milestone

Results Posted

Study results publicly available

June 27, 2011

Completed
Last Updated

July 10, 2012

Status Verified

January 1, 2012

Enrollment Period

2 months

First QC Date

March 31, 2010

Results QC Date

May 27, 2011

Last Update Submit

June 26, 2012

Conditions

Outcome Measures

Primary Outcomes (1)

  • Visibility of the Inversion Indicator on Lens When Lens Was on Participant's Finger, for Example, During Lens Insertion.

    As assessed by the participant retrospectively after one week of wear and recorded on a questionnaire as a yes or no response to the question, "Did you notice an OK mark on the study lens while it was on your finger, for example, during lens insertion?" The positive "yes" responses are reported.

    1 week

Study Arms (3)

nelfilcon A, modified inversion indicator

EXPERIMENTAL

Nelfilcon A investigational contact lenses worn in both eyes on a daily wear, daily disposable basis for one week

Device: nelfilcon A contact lens, modified inversion indicator

nelfilcon A, no inversion indicator

EXPERIMENTAL

Nelfilcon A investigational contact lenses worn in both eyes on a daily wear, daily disposable basis for one week

Device: nelfilcon A contact lens, no inversion indicator

nelfilcon A, inversion indicator

ACTIVE COMPARATOR

Nelfilcon A commercially marketed contact lenses worn in both eyes on a daily wear, daily disposable basis for one week.

Device: nelfilcon A contact lens, inversion indicator

Interventions

Investigational, nelfilcon A, toric, soft contact lens for daily disposable wear, with modified inversion indicator

nelfilcon A, modified inversion indicator

Investigational, nelfilcon A, toric, soft contact lens for daily disposable wear, with no inversion indicator

nelfilcon A, no inversion indicator

Commercially marketed, nelfilcon A, toric, soft contact lens for daily disposable wear, with inversion indicator

Also known as: Focus DAILIES Toric
nelfilcon A, inversion indicator

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Be of legal age and sign written Informed Consent Document. If under legal age, parent or guardian must sign Informed Consent Document and subjects ages 12 through 17 must sign Informed Assent.
  • Willing and able to wear study lenses in both eyes in the available parameters.
  • Light-eyed subjects.
  • Able to achieve 20/40 or better distance visual acuity (VA) in each eye at time of dispensing.
  • Optimal or acceptable fit in each eye at time of dispensing.
  • Willing to wear the study lenses at least 8 hours a day, 5 days a week.

You may not qualify if:

  • Eye injury or surgery within twelve weeks prior to enrollment for this trial.
  • Pre-existing ocular irritation that would preclude contact lens fitting.
  • Currently enrolled in an ophthalmic clinical trial.
  • Evidence of systemic or ocular abnormality, infection or disease which is likely to affect successful wear of contact lenses or use of their accessory solutions as determined by the investigator.
  • Any use of medications for which contact lens wear could be contraindicated as determined by the investigator.
  • RGP contact lens wearer.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Myopia

Condition Hierarchy (Ancestors)

Refractive ErrorsEye Diseases

Results Point of Contact

Title
Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs
Organization
CIBA VISION

Publication Agreements

PI is Sponsor Employee
No
Restriction Type
OTHER
Restrictive Agreement
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 31, 2010

First Posted

April 2, 2010

Study Start

March 1, 2010

Primary Completion

May 1, 2010

Study Completion

May 1, 2010

Last Updated

July 10, 2012

Results First Posted

June 27, 2011

Record last verified: 2012-01